RELATIONSHIP OF DRUG SENSITIVITY OF ACUTE MYELOBLASTIC-LEUKEMIA (AML) CLONOGENIC PROGENITORS TO CLINICAL-FEATURES AND OUTCOME IN CHILDHOOD AML

被引：0
|
作者：
DOW, LW [1 ]
SCHELL, MJ [1 ]
KALWINSKY, DK [1 ]
MIRRO, J [1 ]
机构：
[1] ST JUDE CHILDRENS RES HOSP,MEMPHIS,TN 38101
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1987年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：211 / 211
页数：1
相关论文
共 50 条
  • [21] ADULT ACUTE MYELOBLASTIC-LEUKEMIA (AML) - RESISTANT DISEASE AND RELAPSE PREDICTED BY IN-VITRO DRUG-RESISTANCE TESTING
    VEERMAN, AJP
    KLUMPER, E
    OSSENKOPPELE, GJ
    ROTTIER, MMA
    WESTRA, G
    PIETERS, R
    BLOOD, 1994, 84 (10) : A303 - A303
  • [22] IMPROVED PROGNOSIS IN CHILDREN WITH ACUTE MYELOBLASTIC-LEUKEMIA (AML) WITH AN INTENSIVE INDUCTION-CONSOLIDATION PROGRAM
    SCAGLIONE, C
    MATUSRIDLEY, M
    FREIGEIRO, D
    AVERSA, L
    MURIEL, FS
    KVICALA, R
    PAVLOVSKY, S
    SANTARELLI, MT
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 411 - 411
  • [23] EFFECT OF 6 MONTHS OF CONSOLIDATION PHASE ON THE DURATION OF COMPLETE REMISSION IN ACUTE MYELOBLASTIC-LEUKEMIA (AML)
    SCAGLIONE, C
    EPPINGERHELFT, M
    BUSTELO, P
    PAVLOVSKY, S
    BARROS, C
    BRUNO, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 119 - 119
  • [24] QUANTITATION OF THERAPY INDUCED CYTOREDUCTION IN ACUTE MYELOBLASTIC-LEUKEMIA (AML) - A COMPARISON OF 2 INDUCTION REGIMENS
    HIDDEMANN, W
    ANDREEFF, M
    BUCHNER, T
    WORMANN, B
    ARLIN, Z
    CLARKSON, BD
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 118 - 118
  • [25] MINIMAL RESIDUAL DISEASE IN ACUTE MYELOBLASTIC-LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROMES (MDS) - MOLECULAR CYTOGENETICS PREDICTS CLINICAL RELAPSE
    ANDREEFF, M
    LEAHY, J
    GOODACRE, A
    DRACH, D
    SANCHEZWILLIAMS, G
    PINKEL, D
    DRACH, J
    BLOOD, 1993, 82 (10) : A36 - A36
  • [26] Febrile Neutropenia in Acute Myeloblastic Leukemia (AML) clinical and microbiological features of infectious episodes and evaluation of mortality
    Nunez, M. J.
    Sgromo, M.
    Lacal, V.
    Nunez, S.
    Sabater, L.
    Corazza, R.
    Balinotti, S.
    Veron, M. T.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 84 - 85
  • [27] CORRELATION OF MDR STATUS WITH CLINICAL OUTCOME IN PATIENTS WITH ACUTE MYELOBLASTIC-LEUKEMIA
    HOLMES, JA
    WEST, RR
    WHITTAKER, JA
    JACOBS, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1991, 77 (01) : 130 - 131
  • [28] RADIATION AND HEAT SENSITIVITY OF HUMAN T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) AND ACUTE MYELOBLASTIC-LEUKEMIA (AML) CLONES DISPLAYING MULTIPLE-DRUG RESISTANCE (MDR)
    UCKUN, FM
    MITCHELL, JB
    OBUZ, V
    CHANDANLANGLIE, M
    WOO, SM
    HAISSIG, S
    SONG, CW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 23 (01): : 115 - 125
  • [29] TREATMENT OF ADULT ACUTE MYELOBLASTIC-LEUKEMIA (AML) UNRESPONSIVE TO OR RELAPSING FOLLOWING ARA-C THERAPY
    RAAB, SO
    SHAW, MT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 49 - 49
  • [30] RESULTS OF TREATMENT WITH AN INTENSIVE INDUCTION REGIMEN USING IDARUBICIN IN COMBINATION IN CHILDREN WITH ACUTE MYELOBLASTIC-LEUKEMIA (AML)
    SACKMANNMURIEL, F
    ZUBIZARRETA, P
    FELICE, M
    CHANTADA, G
    CYGLER, A
    ROSSI, J
    BARBIERI, MF
    BLOOD, 1994, 84 (10) : A145 - A145
12345